secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2026-05-19T20:13:42+00:00
Accession:  0001193125-26-230774
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q1 revenue $11.8M (-1% YoY); net loss narrows to $0.5M; Cyclo G6 up 14%
------------------------------------------------------------------------------

- Revenue $11.8M, down 1% YoY; Cyclo G6 product revenue $3.6M (+14% YoY) on 15,500 probes sold.
- Net loss $0.5M ($0.03/sh) compared to $1.7M ($0.10/sh) in Q1 2025; Non-GAAP adjusted EBITDA $0.3M.
- Gross margin 40% vs 43% a year ago, pressured by tariffs and transition to low-cost manufacturers.
- Cash $4.6M; company expects positive cash flow for full year 2026 despite typical Q1 usage.
- FY2026 revenue guidance reaffirmed at $51M-$53M; adjusted opex guided $19M-$19.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000119312526230774/0001193125-26-230774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000119312526230774/irix-20260519.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-230774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer